Managing COVID-19 in the oncology clinic and avoiding the distraction effect
Open Access
- 19 March 2020
- journal article
- editorial
- Published by Elsevier BV in Annals of Oncology
- Vol. 31 (5), 553-555
- https://doi.org/10.1016/j.annonc.2020.03.286
Abstract
No abstract availableFunding Information
- European Research Council
This publication has 6 references indexed in Scilit:
- On the origin and continuing evolution of SARS-CoV-2National Science Review, 2020
- Risk of COVID-19 for patients with cancerThe Lancet Oncology, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Myeloid suppressor cells in cancer and autoimmunityJournal of Autoimmunity, 2017
- Features of Postoperative Immune Suppression Are Reversible With Interferon Gamma and Independent of Interleukin-6 PathwaysAnnals of Surgery, 2016
- Nosocomial infections in patients with cancerThe Lancet Oncology, 2009